What actions can be taken to combat misinformation about health products?

被引：0
|
作者：
Micallef, Joelle [1 ]
Maisonneuve, Herve [2 ]
Muller, Sophie [3 ]
Molimard, Mathieu [4 ]
Begaud, Bernard [5 ]
Cabut, Sandrine [6 ]
Daban, Mina [7 ]
Drici, Milou-Daniel [8 ]
Gatignol, Chantal [9 ]
Grumblat, Anne [10 ]
Guaspare-Cartron, Catherine [11 ]
Lasserre, Bruno [12 ]
Mebarki, Adel [13 ]
Pons, Catherine [14 ]
Prabonnaud, Frederique [15 ]
Raynaud, Catherine [16 ]
Saint-Lary, Olivier [17 ]
机构：
[1] AP HM, Ctr Reg Pharmacovigilance, Serv Pharmacol Clin & Pharmacosurveillance, F-13005 Marseille, France
[2] 30 Rue Faidherbe, F-75011 Paris, France
[3] GSK, Direct Med, F-92150 Rueil Malmaison, France
[4] CHU Bordeaux, Serv Pharmacol Med, F-33000 Bordeaux, France
[5] Univ Bordeaux, Coll Sante, F-33076 Bordeaux, France
[6] Le Monde, F-75013 Paris, France
[7] LMC France, F-13000 Marseille, France
[8] Univ Cote Azur, Hop Pasteur, Dept Pharmacol Clin, F-06001 Nice, France
[9] SG CIPDR MIVILUDES, F-75008 Paris, France
[10] CHRU Jean Minjoz, Pole Pharmaceut, F-25030 Besancon, France
[11] Grp Etud Methodes Anal Sociol Sorbonne, F-75017 Paris, France
[12] Conseil Etat, F-75001 Paris, France
[13] Kap Code, F-75002 Paris, France
[14] Roche, Unite Pharmacovigilance, F-92100 Boulogne Billancourt, France
[15] Journaliste Sante, F-75000 Paris, France
[16] Pfizer, Affaires Publ, F-75014 Paris, France
[17] Univ Paris Saclay, Primary Care & Prevent Team, CESP, UVSQ,Inserm U1018, F-94800 Villejuif, France
来源：
THERAPIE | 2024年 / 79卷 / 01期
关键词：
INFORMATION; DRUG;
D O I：
10.1016/j.therap.2023.10.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：75 / 86
页数：12
相关论文
共 50 条
12345